Citius Oncology (CTOR) Cash Flow: Operating & Free Cash Flow

Citius Oncology Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Citius Oncology, Inc. (CTOR) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Sep 2025	Sep 2024	Sep 2023	Sep 2022
Operating Activities
Net Income	-24.76	-21.15	2.42	0.38
Deferred Income Tax	1.06	0.58	0.00	0.00
Stock Based Compensation	8.32	7.50	0.00	0.00
Change in Working Capital	9.89	13.20	0.41	0.06
Change in Accounts Receivable	0.00	0.00	0.35	0.03
Change in Inventory	-12.65	-2.13	0.00	0.00
Change in Accounts Payable	18.45	16.69	0.00	0.00
Change in Other Working Capital	13.02	12.91	0.06	0.04
Other Operating Activities	8.32	7.50	-3.43	-0.49
Net Cash from Operating Activities	-5.49	0.13	-0.60	-0.05
Investing Activities
Capital Expenditures	-5.75	-5.00	0.00	0.00
Purchases of Investments	0.00	0.00	-1.32	-67.32
Other Investing Activities	-5.75	-5.00	0.00	0.00
Net Cash from Investing Activities	-5.75	-5.00	-1.32	-67.32
Financing Activities
Debt Repayment	0.00	3.80	0.00	0.00
Common Stock Issued	15.17	0.00	0.00	68.04
Other Financing Activities	0.00	1.07	1.66	-0.38
Net Cash from Financing Activities	15.17	4.87	1.66	67.66
Summary
Effect of Forex Changes on Cash	0.00	-0.03	0.00	0.00
Net Change in Cash	3.92	0.00	-0.26	0.29
Cash at Beginning of Period	0.00	0.03	0.29	0.00
Cash at End of Period	3.92	0.00	0.03	0.29
Free Cash Flow	-11.24	-4.87	-0.60	-0.05
Supplemental Disclosures
Interest Paid	0.19	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Citius Oncology Cash Flow

What is Citius Oncology's free cash flow?

Citius Oncology had negative free cash flow of $11.24M in fiscal 2025 (fiscal year ended Sep 30, 2025), operating cash flow of −$5.49M minus $5.75M of capital expenditures.

How much does Citius Oncology spend on capital expenditures?

Citius Oncology spent $5.75M on capital expenditures in fiscal 2025, compared with $5.00M a year earlier.

Does Citius Oncology pay dividends or buy back shares?

Citius Oncology's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition